Inhibition of human platelet aggregation by gangliosides

Thrombosis Research

Volumn 98, Issue 1, 2000, Pages 51-57

  Guglielmone, Hugo A ^a   Daniele, José J ^b   Bianco, Ismael D ^b,c   Fernandez, Eduardo J ^a   Fidelio, Gerardo D ^a  

^a Lab Analisis Clinicos E   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c Centro de Excelencia en Productos y Procesos de Cordoba   (Argentina)

Author keywords

Gangliosides; Phospholipases; Platelet aggregation; Signal transduction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADRENALIN; CALCIMYCIN; FLUOROALUMINATE; GANGLIOSIDE; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GANGLIOTETRAOSYLCERAMIDE; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE; THROMBOXANE A2;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PLATELETS; CATTLE; COLLAGEN; GANGLIOSIDES; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; VASOCONSTRICTOR AGENTS;

EID: 0033997709     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00208-X     Document Type: Article

References (33)

1. Maggio B. The surface behavior of glycosphingolipids in biomembranes. A new frontier of molecular ecology Prog Biophys Molec Biol. 62:1994;55-117.
2. Yates A.J., Rampesaud A. Sphingolipids as receptor modulators. An overview. Ann NY Acad Sci. 845:1998;57-71.
3. Yu R.K., Ariga T. The role of glycosphingolipids in neurological disorders. Mechanisms of immune action. Ann NY Acad Sci. 845:1998;285-306.
4. Ferroni P., Lenti L., Martini F., Ciatti F., Pontieri G.M., Gazzaniga P.P. Ganglioside content of human platelets-differences in resting and activated platelets. Thromb Haemost. 77:1997;548-554.
5. Mazurov A.V., Prokazova N.V., Mikhailenko I.A., Mukjin D.N., Repin V.S., Bergelson L.D. Stimulation of platelet adhesion and activation by ganglioside GD3 adsorbed to plastic. Biochim Biophys Acta. 968:1988;167-171.
6. Valentino L.A., Ladisch S. circulating tumor gangliosides enhance platelet activation. Blood. 83:1994;2872-2877.
7. 2+ mobilization and functional responses in human platelets. Glycobiology. 6:1996;347-353.
8. Santoro A. Inhibition of platelet adhesion to fibronectin, fibrinogen and Willebrand factor substrates by complex gangliosides. Blood. 73:1989;1645-1654.
9. Tubaro E., Belogi L., Croce C., Cavallo G., Guida G., Borelli G.P. Antiplatelet effects of a new de-N-acetyl-lyso-glycosphingolipid. Eur J Pharmacol. 248:1993;175-183.
10. Cunningham M.T., Olson J.D., Koerner T.A. Glycosphingolipid inhibition of the adhesion of thrombin-activated platelets to surfaces is potentiated by albumin. Glycobiology. 3:1993;331-337.
11. Lapetina E.G. The signal transduction induced by thrombin in human platelets. FEBS Lett. 268:1990;400-404.
12. Bianco I.D., Fidelio G.D., Maggio B. Modulation of phospholipase A2 activity by neutral and anionic glycosphingolipids in monolayers. Biochem J. 258:1989;95-99.
13. 2 activity. A monolayer study. Biochim Biophys Acta. 1026:1990;179-185.
14. 2 activity against dipalmitoyl- and dilauroylphosphatidyl-choline in small unilamellar bilayer vesicles and mixed monolayers. Biochim Biophys Acta. 1190:1994;137-148.
15. Daniele J.J., Maggio B., Bianco I.D., Goñi F.M., Alonso A., Fidelio G.D. Inhibition by gangliosides of Bacillus cereus phospholipase C activity against monolayers, micelles and bilayer vesicles. Eur J Biochem. 239:1996;105-110.
16. Correa S.G., Bianco I.D., Riera C.M., Fidelio G.D. Anti-inflammatory effect of gangliosides in the rat hindpaw edema test. Eur J Pharm. 199:1991;93-98.
17. Lazarewicz J.W., Salinska E., Wroblewski J.T. NMDA receptor-mediated arachidonic acid release in neurons. Role in signal transduction and pathological aspects Bazan N.G., Murphy M.G., Toffano G. Neurobiology of Essential Fatty Acids. 1992;73-89 Plenum Press, New York.
18. Bressler J.P., Belloni-Olivi L., Forman S. Effect of ganglioside GM1 on arachidonic acid release in bovine aortic endothelial cells. Life Sci. 54:1994;49-60.
19. 2+ in human blood platelets. Biochim Biophys Acta. 1127:1992;221-225.
20. 2+ level in different cell types. Life Sci. 57:1995;449-456.
21. Pumiglia K.M., Huang C.K., Feinstein M.B. Elevation of cAMP, but not cGMP, inhibits thrombin-stimulated tyrosine phosphorylation in human platelets. Biochem Biophys Res Commun. 171:1990;738-745.
22. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
23. Watanabe Y., Taniguchi M., Fukamachi N., Sakuma M., Kobayashi B. Effects of gangliosides on cell maturation of murine megakaryocytes in a liquid culture system. Cell Struct Funct. 15:1990;79-84.
24. Nakamura M., Kirito K., Yamanoi J., Wainai T., Nojiri H., Saito M. Ganglioside GM3 can induce megakaryocytoid differentiation of human leukemia cell line K562 cells. Cancer Res. 51:1991;1940-1945.
25. Valentino L.A., Ladisch S. Tumor gangliosides enhance alpha2 beta1 integrin-dependent platelet activation. Biochim Biophys Acta. 1316:1996;19-28.
26. Fang L.H., Lucero M., Kazarian T., Wei Q., Luo F.Y., Valentino L.A. Effects of neuroblastoma tumor gangliosides on platelets adhesion to collagen. Clin Exp Metastasis. 15:1997;33-40.
27. Vasylevskaya V.V., Zvezdina N.D., Korotaeva A.A., Prokazova N.V. The influence of gangliosides on serotonin binding and uptake by human platelets. Platelets. 6:1995;37-42.
28. Daniel J.L., Molish I.R., Rigmaiden M., Steward G. Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response. J Biol Chem. 259:1984;9826-9831.
29. Blockmans D., Deckmyn H., Vermylen J. Platelet activation. Blood Reviews. 9:1995;143-156.
30. Lapetina E.G. Inositol phospholipids and phospholipase C in platelet receptor transduction. Prog Clin Biol Res. 283:1988;499-511.
31. Kanda T., Ariga T., Yamawaki M., Yu R.K. GM3 regulates protein kinase systems in cultured brain microvascular endothelial cells. J Neurochem. 61:1993;1969-1972.
32. Yates A.J., Saqr H.E., Van Brocklyn J. Ganglioside modulation of the PDGF receptor. A model for ganglioside functions. J Neurooncol. 24:1995;65-73.
33. Herman A.G. Rationale for the combination of anti-aggregating drugs. Thromb Res. 92(1 Suppl 1):1998;S17-S21.